SLIDE 9 TMS for Alzheimer’s disease-Neuronix Stimulation Sites
Courtesy Dr D. Press
Results of Initial NeuroAD trials
- Neuronix has completed a phase III trial of
TMS+Cognitive therapy in mild-moderate AD
- Prospective, double-blind trial of 130
patients
- Initial results presented at meetings
showing efficacy in the mild AD patients but not in overall group
Courtesy Dr D. Press
Berenson-Allen Center for Noninvasive Brain Stimulation Beth Israel Deaconess Medical Center Harvard Medical School Harvard Medical School
!"#$% !"#$%&&'#()) !"#$% &"% &"% &"% &"%%
$'()*+%#,-)*% ./0!)+%123)%%
!"#$% &"% &"% !"#$% !"#$%
!"#$'*(%+,)-%./')0"&)1.2.#3)"0)&145)+#/)6'7+8."&+,)17'&+*9)
:#('&,'+8'/)
;:1<:=)5>55:?=)) 6>1;>>=)5>55:?=))
5'@%'#A+,)) !"#$%
!"#$#%&"'()'#*'+',-./
Berenson-Allen Center for Noninvasive Brain Stimulation Beth Israel Deaconess Medical Center Harvard Medical School
/012(3(456'7-,7%/+86(#&(1+9-/(:%8/%55#"%(:#5-/$%/(
19-6$&';7&'<"=>$58&'?7&'2"4@&'A7'B7&'*C6D&'A7'E7&'F'A5-6&'G7'H()IJK7'23+C#%"-$9C6'5BG2'"-='L6.4D9%D$5"L.'3-'+"095' =$L5$663:$'=3695=$5M'/#3-34"#'9C%49+$6'"-='L5$=34%956'N59+'"'#"58$'-"%C5"#36%34'6%C=.7'O5"3-'2%3+C#"%39-&'IIH(K&'PPQRPST7
^ _(#"&A&*&)2'`'<*&>&<#*'3;)<3@('34'"&@;*)#>(3;"'%!56']'0!'&>'588 ^ >'a'.K/'=#)&(>)"+'>3>D="2<13)&<'588'3%'?2")12@&#' ^ !%(#)@(>)'%($&@(>N'5&>Z',DX'?#2"'=(%'G((Cb'5#c',c'=(%'?#2+'I'34'"(""&3>"'Q#%&(?
012(;&,%/"%&,#-&(<=>(1#&?( !38D&'#9U&'95'>9%D'6$VC$-%3"##.'' P&$1'4%(d;(><2'WP_YN'.-'PV'*(4)' 8:0_E+'..-D.,-e'O5!+'X-')%#&>"'34' f'"'?;%#)&3>+'&>)(%D)%#&>'&>)(%Q#*' X-"+'.f--'=;*"("'=(%'"(""&3> :3G'4%(d;(><2'W:_YN'.'PV'%&$1)' 8:0_E+'..-D.,-e'5!+'.,-')%#&>"'34' .-"'?;%#)&3>+'M!M'."+'.,--'=;*"("' =(%'"(""&3> :_']'P_N':3G'4%(d;(><2'W.---' =;*"("'=(%'"(""&3>Y')1(>'P_' =%3)3<3*'#)'4;**'*(>$)1 456'7-,7%/+86(;&,%/"%&,#-&(( 0%&@#%&*2'EB!+'"=(<&4&<'#==%3#<1' &>?&Q&?;#*&V(?'A#"(?'3>'<*&>&<#*'>((?"' 34'&>?&Q&?;#*' 8;%#)&3>N'Lf'@&>;)("'' 8(<&"&3>')3'<3>)&>;(')%(#)@(>)'G(%(' A#"(?'3>'' .Z O("=3>"(')3')%(#)@(>)' ,Z E*&>&<#*'(Q#*;#)&3>'34'"2@=)3@' "(Q(%&)2'' XZ 0#)&(>)'%(d;(")'
/012(3(456'7-,7%/+86(#&(1+9-/(:%8/%55#"%(:#5-/$%/(
Berenson-Allen Center for Noninvasive Brain Stimulation Beth Israel Deaconess Medical Center Harvard Medical School
Donse et al (2018)
B8M'<1#>$('3Q(%')1('<3;%"('34')%(#)@(>)'43%')1(')3)#*'$%3;='WFa.K/Y' #>?')1('43**3GD;='$%3;='W>a[XYZ'S%%3%'A#%"+'6S5
O("3>?(%"'g6Z' F3>%("=3>?(%" P&$1'g6Z':3G' _%(d;(><2' *%5@.,5
- 5(#>'B8M'"<3%("'"&$>&4&<#>)*2'%(?;<(?'#4)(%'
%!56']'0!'WffZKe'%(?;<)&3>Y
- F3'?&44(%(><("'&>'3Q(%#**'B8M'"<3%('43;>?'
A()G((>'P_'`':_'=%3)3<3*'$%3;="''
- O(@&""&3>'%#)('34'f/e'WhX['@3>3)1(%#=2Y
- O("=3>"('%#)('34'//e'W,KDfJ'@3>3)1(%#=2Y
Berenson-Allen Center for Noninvasive Brain Stimulation Beth Israel Deaconess Medical Center Harvard Medical School
Donse et al (2018)
P L E A S E D O N O T C O P Y